Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004979747 | SCV005575313 | uncertain significance | Inborn genetic diseases | 2024-12-10 | criteria provided, single submitter | clinical testing | The c.3034G>C (p.E1012Q) alteration is located in exon 8 (coding exon 8) of the EMILIN1 gene. This alteration results from a G to C substitution at nucleotide position 3034, causing the glutamic acid (E) at amino acid position 1012 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |